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CH.A.P'rER ONE 
I. PURPOSE 
The purpose of this research is to 
develop a method for the assay of catecholamj_ne 
derived catecholaldehydes in brain tissue. 
Numerous workers have suggested that these 
endogenous aldehydes are of physiological importance 
in brain function (75). However, little or nothing 
is known about their in vivo concentrations in 
normal, pathological or drug states. Electron 
capture gas chromatography (EC/GC), which has the 
capability of detecting picogram quantities of 
particular catechol derivatives, will be utilized 
in this study. 
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Jr. INTRODUCTION 
Natural catecholamines ( CAs ) like dopa-
mine (DM) and norepinephrine (NE), as well as the 
indoleamine serotonin, are important neurotransmitters 
in the central nervous system (CNS) (1). The 
localization of these neurotransmitters in particu-
lar brain tracts has been established and their 
relationship to specific animal behaviour has in 
part been explained (2-6). NE is the transmitter 
released from the terminals of postganglionic neurons 
of the sympathetic nervous system (?). In addition, 
NE and DM occur in the brain and spinal cord 
of vertebrates (8-9). Histochemical fluorescence 
techniques have revealed the distribution of CA-
containing neurons in the CNS (10). Histochemical 
and biochemical studies have also revealed the pre-
sence of separate neuronal systems in the CNS in 
which the predominant CA is DH rather than NE. 
NE-containing nerve terminals are widely distributed 
throughout the CNS with a particular abundance in 
the hypothalamus (8). D~1-containing neurons are parti-
cularly abundant in the striatum (11). Epinephrine 
(E) is present in very small amounts in the mamma-
lian CNS ( 12). These three CAs are v-ery high in 
levels in the chromaffin tissue of the adrenal 
medulla ( 13). 
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A. BIOSYNTHESIS OF CATECH01fl.HINES 
CA-containing cells synthesize their endo-
genous amine content from the plasma amino acid 
1-tyrosine by a pathway(Fig.l) suggested by Blaschke 
in 1939 (14). The evidence for this pathway comes 
from studies of the synthesis of CAs in the 
adrenal medulla. In these studies it was shown that 
radioactivily-labeled tyrosine or 3,4-dihydroxyphenyl-
alanine(1-DOPA) can be converted into DM, NE, & E 
both in vivo and in vitro(l5-18). Tyrosine hydroxy-
lase converts 1-tyrosine to 1-DOPA. The enzyme occurs 
in the adrenal medulla, brain and sympathetically 
innervated tissues(19-20). Tyrosine hydroxylase requires 
dihydrobiopterin as a cofactor(19). The hydroxylation 
of tyrosine by tyrosine hydroxylase is the rate 
limiting step in the biosynthesis of CAs(2l). 1-DOPA 
is decarboxylated to DN by the enzyme aromatic 
1-amino acid decarboxylase. It is named so, as the 
same enzyme apparently decarboxylates 1-DOPA, 1-5-
hydroxytryptophane and 1-histidine(22). Dopamine-beta-
hydroxylase requires ascorbic acid as a cofactor 
(23,24). Phenylethanolamine-N-methyl transferase converts 
~m to E. This enzyme is not present in significant 
amounts in the CNS, but studies by Fuller suggest 
that it still may be important(68). It 
-3-
OH2-cH( cooH_)"'!""NH_z_~~-~~HoocH2-cH C cooH )NH2 HO- Tyrosine Hydroxyla?e A HO #' 
L-Tyrosine L-Dihydroxyphenyl alanine 
DOPA 1 
Decarboxylase 
HO-o-CH2-cH2-N.tt2 
HO-
L-Dopamine 
Dopamine-beta- l 
hydroxylase 
P-N-MT 
HO- o~-CH(OH)-CH2-NH2 
HO- # 
L-Norepinephrine 
HO- o-CH(OH)CH2~THCH3 
HO-I ~ 
L-Epinephrine 
Fig. 1, Biosynthesis of catecholarnines. 
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requires S-adenosyl L-methionine (SAMe) as a methyl 
donor and will N-methylate a variety of beta-phenyl-
ethanolamines (25, 26). 
B. METABOLISM OF CAs 
The 
by 
in vivo metabolism ----~-- of CAs has been 
activity 
NE, DM and 
(Fig. 2). 
elucidated the 
tritium- labeled CAs 
E are metabolized 
use of 
(28, 
high specific 
29, 30, 31). 
in a similar fashion 
Monoamine ·oxidase (MAO) and catechol-0-methyl trans-
ferase (COMT) are the major enzymes for the meta-
bolism of CAs. M~O oxidatively deaminates the CAs 
forming the corresponding aldehyde. COMT C-methylates 
the CAs by transferring a methyl group of SAMe 
to the meta-hydroxyl of catechol compounds. COMT 
is not very specific 
methylate aldehydes (32) 
the action of MAO on 
HAO is also 
in its 
and 
CAs. 
action. It 
acids (32) 
can 
formed 
0-
from 
and it 
nephrine 
pending 
oxidized 
non specific in its action 
monoamine including normeta-
dopamine forming the corres-
aldehyde intermediate can be 
will act on any 
and 3-0-methyl 
aldehyde. The 
can be 
to the acid 
reduced to the 
-5-
by aldehyde dehydrogenase or 
alcohol by aldehyde reductase. 
COMT 
HO- 0· -CH(OH)-CH20H 
HO- ~ 
3,4~Dihydroxy-phenyl 
.a'lycol CH3o~-CH(OH)-CH2-NH2 c 
HO- ~· COMT 
Normetanephrine 
CH3o~ -CH(OH)-CHO 
HO- ~ 
Aldehyde 
dehydrogenase 
HOO" -CH(OH)-COOH 
HO ~ 
3,4-Dihydroxy-
mandelic acid 
C0!'-1T 
3-Methoxy-4-hydroxy 
mandelic acid 
Fig. 2 Metabolism of catecholamines. 
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The studies of the metabolism of CAs in 
the CNS has been hampered by the existence of a 
blood brain barrier; which prevents circulating 
labeled CAs from entering the CNS. The metabolism 
of labeled CAs in the intact brain has been 
studied after injecting small amounts of labeled 
CAs into the CSF(29,30). The metabolism of NE and 
DM has also been studied in brain homogenates(31). 
These studies confirm that NE and DM are metabolized 
by 0-methylation and deamination in all regions of 
the brain, as in the periphery. The major end 
products of NE metabolism in the brain are reduced 
alcohols, rather than acids. The alcohols are 3-methoxy 
4-hydroxyphenylglycol(r-':HPG) and 3,4-dihydroxyphenylglycol 
(DHPG)(31). DM is metabolized principally to an acid 
both in intact brain and tissue slices. The wajor 
metabolites of m1 are 3-methoxy :>4-hydroxyphenylacetic 
acid(homovanillic acid) and 3,4-dihydroxyphenylacetic 
acid(31). 
C. ENZYMES OF CATECHOLAMINE 1'1ETABOLISM 
a. CATECHOL-0-NETHYL TRANSFERASE 
COMT from rat liver utilizes S-adenosyl-
L-methionine as the methyl donor and has an absolute 
-7-
requirement for magnesium or other divalent cations 
(32). CAs are mostly methylated on the meta position 
but the para position can also be methylated to 
a certain extent depending on its nucleophilic 
characteristics. DM yields 900/o meta and 10% para 
a-methylated products in in vitro experiments(33). 
There is no evidence that 3,4-dimethoxy products 
can be formed to any significant degree by this 
enzyme (34). 
b. MONOAMINE OXIDASE 
MAO is a poorly characterized enzyme. 
Partial chromatographic separation has been reported 
and it seems that MAO exists as isoenzymes(35). 
Purified preparations of MAO contain enzyme bound 
to flavin groups (36, 37,38). Hfl.O catalyzes the oxidative 
deamination of a wide variety of monoamines(Fig.3) 
(27). Oxidative deamination of monoamines takes 
place in two steps (Fig.4)(27). In the anaerobic 
step, flavin, bound to MAO, is reduced and in 
the aerobic step the flavin groups are oxidized to 
give MltO(FAD) which can again take part in oxidative 
deamination. The aldehydes produced are further 
-8-
R--+~-- NHR' MAO 
0 + NH R' 2 +H202 
Fig. 3 Oxidative deamination of monoamines by MAO. 
(i) 
R ,,_ N:r!R' 
+ HAO(FAD) 
(ii) ~ NR' 
H 
+ H20 
(iii) MAO(FADH2 ) + 02 
Fig. 4 Two steps of NAO action 
R 
R 
? 
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H 
NR' MAO(FADH2 ~ 
H 
0 
+ NH2R
1 
H2o2 + V~O(FAD) •••••••• Aerobic 
~ 
Anaerobic 
metabolized(vide supra). MAO exhibits stereochemical 
selectivity in favor of the naturally-occurring 
L-anantiomers of optically active amines such as 
NE and E (40). 
In vitro studies have been done for the 
measurement of monoamine oxidase activity. In 
these studies either the disappearance of o2 (as 
measured with an oxygen electrode), the appearance 
of NH3 , or the appearance of products(methyl amine 
or hydrogen peroxide) have been followed(43). In 
histochemical studies brain slices are incubated 
for several hours at 37°c · o l.n 2 in presence of 
serotonin and traces of heavy metals(Co,Fe,cu,Mo, 
etc.) which accelerate pigment formation. The slices 
are washed and embedded in paraffin, after which 
sections are cut, deparaffinized, dehydrated in 
alcohol and mounted in cedar oil. MAO activity is 
measured by the formation of dark brown pigment. 
The pigment is produced from 5-hydroxyindolacetalde-
hyde(44,45). 
Microfluorimeteric determination of MAO 
activity is based on the rate of disappearance 
of serotonin in tissue homogenate,incubated at 
37°c J.. n presence of oxygen; and the amount of 
serotonin is measured by a fluorescence technique 
-10-
(46,47). A colorimetric method for the measurement 
of MAO activity is based on the treatment of 
amine samples and ~ffiO with alkaline 2,4-dinitro-
phenyl hydrazine. The aldehyde derived from the 
amine reacts with hydrazine to produce a charac-
teristic color(48). 
c. ALDEHYDE DEHYDROGENASE & ALDEHYDE REDUCTASE 
Recently Tabakoff and co-workers have 
reported that + NAD -dependent aldehyde dehydrogenase 
carries out the oxidation of biogenic aldehydes 
in brain(41). :t-IAD+ is loosely bound to the enzyme 
in most tissues for example kidney and liver in 
rat(39). Rat liver aldehyde de~ydrogenase exists in 
two forms, one present in the mitochondrial matrix 
and another form present in the soluble portion 
of the cytoplasm(53). A third form of aldehyde 
dehydrogenase has been reported which is present 
in the microsomes(54).The mitochondrial enzyme has 
unequal distribution in the brain, with highest 
concentration in the caudate nucleus(55). With 
regard to the mechanism of action of aldehyde 
dehydrogenase, the mammalian enzyme from both liver 
and brain bind to NAD+, followed by binding of 
the aldehyde to give a ternary complex(56). 
-11-
The aldehyde 
nic aldehydes to their 
NADPH-dependent aldehyde 
and characterized from 
D. BIOGENIC ALDEHYDES 
reductase reduces the bioge-
corresponding alcohols. 
reductase has been isolated 
bovine brain (57). 
As stated, biogenic aldehydes are formed 
by the oxidative deamination of biogenic amines 
by the action of 
are deaminated by 
oxidase to form an 
for the formation 
MAO. Some amines like mescaline 
diamine oxidase or mescaline 
aldehyde (50). Another path 
of biogenic aldehydes is by 
transamination. The neuroamine precursor amino acids, 
5-hydroxytryptophan and DOPA can be transaminated 
and then 
aldehydes 
decarboxylated to form the respective 
(51). 
E. J~PORTANCE OF BIOGENIC ALDEHYDES 
Available information concerning the bio-
genic aldehydes indicate the possible in vivo 
participation of biogenic aldehydes in (a) the 
regulation of tissue respiration and oxidative 
-12-
phosphorylation; (b) binding to macromolecular cell 
components; (c) stimulation of glucose oxidation 
by pentose phosphate shunt; (d) alteration in NADl 
NADH levels; (e) condensation with parent amines 
and other products to form tetrahydroisoquinoline 
or carboline derivatives and (f) regulation of 
citric acid cycle. 
Deamination products of a number of bio-
genic amines ( i.e. NE, E, DM & serotonin) inhibit 
the cytochrome oxidase activity of rat liver mito-
chondria (62). Treatment of mitochondria with inhi-
biters of MAO, such as pargyline, prevents the 
inhibition of cytochrome oxidase activity of rat 
liver mitochondria. From these observations it seems 
that biogenic aldehydes could be regulatory factors 
in the electron . .. t;ranspor~. chain; in other words, 
biogenic aldehydes could be controlling tissue res-
piration and oxidative phosphorylation. Binding of 
aldehydes to -NH2 and -SH groups in cell compo-
nents has been suggested to be of physiological 
importance in states such as sleep (63). Aldehydes 
of serotonin and E stimulate the oxidation of glu-
cose by pentose phosphate shunt in beef pituitary. 
-13-
This effect was also noted with benzaldehyde and 
it requires the presence of NADPH. As glucose-6-
phosphate dehydrogenase and 6-phosphogluconate dehydro-
genase both depend on the presence of NADP+ for 
their catalytic activity, the reduction of aldehydes 
by NADPH-dependent aldehyde reductase with the simul-
taneous production of NADP+ would probably act as 
a control mechanism for channeling glucose through 
this metabolic pathway (64, 65). Only 5-8 % of 
glucose is metabolized by pentose phosphate shunt 
in brain, but this pathway might be particularly 
important in the synaptic region (66). The meta-
bolism of aldehydes by aldehyde dehydrogenases pres-
ent in neural tissue would vary the NAD+ /NADH 
ratio in cytosol as well as in mitochondria. Hence 
the activity of regulatory enzymes of glycolysis 
i.e. phosphofructokinase might be effected by 
feed back inhibition due to high NADH concentra-
tion. 
The aldehyde reductases are incapable of 
utilizing the short chain aldehydes, formaldehyde 
or acetaldehyde (AcH). AcH is primarily metabolized 
by aldehyde dehydrogenase in brain tissue. This 
type of exogenous aldehyde would compete with the 
dehydrogenase oxidation of natural biogenic aldehydes. 
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A shift in the disposition of biogenic aldehydes 
has been observed in tissues of animals and human 
subjects during ethanol metabolism and has been 
explained partly by this inhibition by AcH (58). 
Along with this change in metabolic pattern after 
ethanol (EtOH) or AcH, there are changes which 
take place in the CNS. The alcohol derivatives 
produced in the CNS would be circulated through 
the liver and kidney, where these alcohol deri-
vatives are exposed to alcohol dehydrogenase,which 
may convert the alcohols to aldehydes and again 
make them available for oxidation. The Km's and 
maximal velocity for biogenic aldehydes favor their 
oxidation and the inhibition of oxidative pathway 
would most probably lead to an increase in the 
steady state level of these aldehydes (67) 
Due to these increased levels of alde-
hyde intermediates, side reactions may occur. One 
such reaction is the condensation of aldehydes, as 
in the case of DM derived biogenic aldehyde with 
the parent amine, to form a 1,2,3,4,-tetrahydroiso-
quinoline derivative i. e. tetrahydropapaveroline(THP) 
(59). Direct condensation of biogenic amines with 
acetaldehyde leads to the formation of 1-methyl 
tetrahydroisoquinolines(60). The theory has been 
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advanced that the formation of the alkaloids after 
EtOH administration might be associated with EtOH 
addiction(60,69,70). The condensation of acetaldehyde 
with a catecholamine to form a tetrahydroisoquino-
line probably proceeds through a schiff base inter-
mediate(60). It has been suggested that mild reducing 
agents such as ascorbate or glutathione can reduce 
this schiff base, thus preventing the cyclization 
product(?O). 
Finally in support of the regulation of 
citric acid cycle by biogenic amines; the deamination 
products of a number of biogenic amines(NE,E,DM & 
serotonin) inhibit the activity of succinate 
dehydrogenase(71,72), This suggests that biogenic 
aldehydes might be a controlling factor in citric 
acid cycle. 
Nevertheless, while the functions of biogenic 
amines are quite well established, the roles of 
biogenic aldehydes are still very speculative. There 
is much to learn about the biogenic aldehydes, 
particularly the catecholaldehydes, and their biolo-
gical implications. The steady state catecholaldehyde 
levels are low but as the catecholaldehydes are no 
doubt very active metabolites, the determination of 
-16-
these low levels of catecholaldehydes is of great 
importance. A sensitive and reliable method which 
can measure catecholaldehydes in the subnanogram 
range in brain and nerve tissue is required. 
Therefore the purpose of this study is to explore 
various trapping and derivatization procedures, 
combined with gas chromatography with the very 
sensitive electron capture detector for catechol-
aldehydes. 
-17-
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I. NATERIALS 
A. CHEMICALS 
CHAPTER TWO 
L-NE, L-DM, L-E, L-epinine, L-DHPG were 
purchased from Regis Chemical Company. Ethyl acetate, 
acetonitrile(sequanal grade) and derivatizing reagents 
HFBA(heptafluorobutyric anhydride),PFPA(pentafluoro 
propionic anhydride) and TFAA(trifluoroacetic anhydride) 
were purchased from Pierce Chemical Company, and 
were stored at a temperature below or equal to 
-10°C. Eastman Organic Chemicals supplied 2,4-di-
nitrophenyl hydrazine. Sodium cyanoborohydride was 
obtained from Ventron Alfa Inorganics Inc. Methyl-
amine and hydroxylamine hydrochloride were purchased 
from Matheson, Coleman and Bell. Phosphoric acid 
(85%), glacial acetic acid and methanol were 
purchased from Mallinckrodt Chemicals. 3 DL-NE-7- H 
in 0.2N acetic acid, specific activity 500mC/mM 
was purchased from ICN Tracerlabs. Pentafluorophenyl · 
hydrazine was purchased from PCR Inc. Nitrogen 
(zero grade), air(zero grade), hydrogen(zero grade) 
and nitro.gen(99. 9%) were purchased from Liquid 
Carbonic. 
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B. G.C. EQUIPMENT AND CONDITIONS 
A Varian 
with 6~i electron 
detectors was used. 
20-30 rnl/min were 
2100 gas 
capture 
Carrier 
routinely 
chromatograph equipped 
and H2 flame ionization 
gas flow rates between 
used. U shaped glass 
columns, 2 mm i .d. z.. 6 ft length were packt:d 
with GEXF- 1105, SE- 30, or OV- 17 on ~as Chrom Q~ 
80/100 m~sh~ 
II. METHODS 
A. PREPARATION OF ACTIVATED ALUHINA 
Activated alumina (Woelm neutral activity 
grade I ) was· pre.pared by Anton and Sayre's method 
(73). In all catechol extraction experiments activity 
grade I alumina was used. An outline for the 
preparation of activated .. · alumina is as follows: 
100 gm Al2o3 was added to 500 ml of 2N HCl in 
a .large beaker. The. contents of the beaker were 
heated to 90-100°C with continuous stirring for 
45 min. The supernatant was discarded and residue 
was washed twice with fresh 250 ml of 2N HCl at 
0 70 c. The alumina was washed with distilled water 
until pH of washings was 3-4. The alumina was 
-19- I I 
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stored in an incubator under vacuum. 
B. PREPARATION OF COLUMN PACKINGS 
Column packings are mostly prepared by 
slurry method or filtration method. 
1. Slurry method is used to prepare packing when 
more than 5% liquid phase loadings are required. 
General outline for this method is as follows: 
Volume of coated packing required to fill a column 
is given by the f,o.rmula: 
Volume ( cc.) 
The volume of the solid 
fill column and an extra 
154 X Length of column 
in feet X (Inside diameter 
of column in inches) 2 
support was measured to 
10-15 cc was added to 
compensate for handling losses. It was weighed 
and 
the 
was 
enough appropriate solvent was added to wet 
solid support. The weight of the liquid phase 
calculated from the following formula: 
Vveight of liquid phase = % loading X Weight 
of solid support 
100-%loading 
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The liquid phase 
dissolved liquid 
support. The whole 
was dissolved 
phase was then 
solution was 
in solvent. 
added to 
stirred to 
This 
the solid 
mix it 
uniformly. The excess solvent was removed on a 
vacuum rotary evaporator. The packing was dried at 
45°c overnight and the columns were packed as 
usual. 
2. The filtration method is used to prepare 
packing with less 
The whole procedure 
The volume of solid 
than 5% liquid phase loading. 
for this method is as follows: 
support was measured to fill 
the column and an extra 10 cc of solid support 
was added to compensate for handling losses. The 
solid support was weighed and the required liquid 
phase weight was calculated from the weight of the 
solid support. The liquid phase was dissolved in 
solvent(volume of solvent is twice the volume of 
solid support).The solid support was added to the 
liquid phase with constant stirring. The excess 
solvent was removed on a vacuum rotary evaporator. 
Final traces of solvent were removed by leaving 
overnight at 45°C. The dry packing was packed in 
glass columns. The fresh packed columns were 
conditioned for 24 hr with a small nitrogen 
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flow at appropriate temperatures, unattached to the 
detector. During the conditioning period, the EC 
detector inlet was capped to prevent any diffusion 
of gases into the EC detector. 
C. GENERAL PREPARATION OF FLUOROACYL DERIVATIVES 
Fluoroacyl derivative was prepared by 
treating 1 mg of the catechol compound with 0.1 
ml of acetonitrile and 0.2 ml of HFBA. The 
mixture was allowed to stand at room temperature 
for 20 min. The solution was evaporated to 
dryness with a N2 stream. The residue was dissolved 
in EtOAc and subjected to EC/GC analysis. 
D. ESTABLISHING OPTIMUH EC/GC CONDITIONS 
The electron capture (EC) detector is a 
very sensitive 
sensitivity of 
part of the gas 
the EC detector 
chromatograph. The 
can be affected 
by a number of factors. If the carrier gas (N2 ) 
has more than 5ppm oxygen or water as contaminants, 
the detector sensitivity and standing current decrease. 
The sensitivity of EC detector is directly related 
to standing current. The base line on the 
chromatogram is the result of a standing current 
of the order of 10-9 amperes or higher. For 
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measuring the standing current the range on the 
electrometer is adjusted to 10-9 and attenuation 
is adjusted to 2. The pen is adjusted to zero 
and the EC cell is turned to OFF position 
on the electrometer. As there is no current the 
pen moves. If the deflection is 60% or higher 
the detector is ready for EC/GC analysis. If 
the true standing current is 60% or more the 
sensitivity of the detector is considered to 
be adequate. 
The EC/GC response to a compound is 
checked with standard solutions of lindane in 
EtOAc or another appropriate solvent. A sharp 
single peak for lindane, with the minimum 
detectable amount of about 1-5 pg, and a 
single peak for solvent assures that the 
instrument is in good working condition. 
E. OBTAINING .STANDARD CURVES 
A known amount of catecholamine is deriva-
tized by treating with HFBA and AN according 
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· to the procedure described already. The fluoroacyl 
derivative is dissolved in EtOAc and various 
dilutions are injected into the GC. Peak heights 
are directly proportional to the amount of sub-
stance injected in the linear range of that 
compound. The standard curves are drawn in the 
linear range of the detector for each particular 
substance. The concentration is plotted against 
peak height on a graph paper to get the stan-
dard curve. 
F. PREPAR!tTION OF DHPAcH FROH E OR NE(74) 
To 5 microliter of 3H-NE(500mC/mM),1 ml 
of 1 N HCl04 , containing 5 mM Na2s2o3 ~ was 
added. The pH was adjusted to 6 .with 0.2 N NaOH. 
Activated Al2o3 (500 mg) was added and the pH was 
further adjusted to 8-8.2 with 0.2 N NaOH. Follow-
ing 10 min of mechanical shaking, the supernatant 
was discarded and the Al2o3 was successively 
suspended in three 2-ml portions of distilled 
H2o, and finally was shaken 10 min at room tem-
perature in 2 ml 0.2 N HCl. The HCl supernatant, 
containing eluted NE, was decanted. The total 
volume of the eluate was 3 ml. A 25 microliter 
aliquot of the acid supernatant was added to 
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10 ml of PPO fluor in a counting vial and 
counted thrice for 5 min in a Beckman Scintillation 
Spectrophotometer. 
Purified 3H-~~ and 150.2 mg of NE were 
added to 
to 125°C 
3 ml of 85% H3Po4• The mixture was heated 
and then immediately poured into 30 ml 
of distilled H2o. The solution was allowed to stand 
at room temperature for 90 min. The aqueous acid 
solution was extracted twice with 15 ml of EtOAc. 
The combined EtOAc extracts were washed twice 
with 5 ml of distilled H2o. The volume of EtOAc 
was reduced to 13 ml with N2 • 
Counting efficiency 
determined using an internal 
(2.06 X 106 dpm/ml) was used 
of the instrument was 
standard. 3H-Toluene 
as the internal 
standard. The fraction of the activity left at the 
time of the experiment was 0.813. Accurately 
measured 24 microliter of 3H-toluene was added to 
the vials containing 25 microliter of purified 
3H-NE in 10 ml PPO. It was counted three times 
for 5 min each. After preparation of DHPAcH(total 
volume 13 ml), a 20 microliter aliquot was added 
to 10 ml PPO in glass vials and counted three 
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times for 5 min each. Accurately measured 20 micro-
liter of 3H-toluene was added to the vials and 
counted three times for 5 min each. From these 
observations the % recovery was calculated. 
In other experiments DHPAcH was made 
without any addition of radioactive carrier. This 
solution of aldehyde in EtOAc was used for the 
preparation of various derivatives which follow. 
An attempt was made to purify DHPAcH by 
crystallization or bv 
" 
distillation. Efforts to get 
a pure oil of DHPAcH by vacuum distillation were 
unsuccessful. A similar problem was faced by 
Fellman and the aldehyde could only be obtained 
in the impure form(74). 
G. fORMATION OF 2,4-DNP HYDRAZONE OF DHPAcH & 
ITS DERIVATIZATION FOR ECfGC ANALYSIS. 
An estimated 0.33 mM of DHPAcH in EtOAc 
was treated with 0.50 mM of 2,4-dinitrophenyl 
hydrazine dissolved in 2 ml of methanol, and 1 rnl 
of glacial acetic acid. The mixture was allowed 
to stand at room temperature. A yellow precipitate 
appeared slowly(addition of a small amount of H20 
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increased the rate of precipitation) and within 30 
min the precipitation appeared to be complete. The 
yellow crystals of 2,4-DNP hydrazone of DHPAcH 
were separated by suction filtration, washed with 
absolute alcohol and dried under vacuum. The M.P. 
was found to be 170°C, in agreement with the 
literature(74). 
An accurately weighed 1 mg of 2,4-DNP 
hydrazone of DHPAcH was treated with HFBA and 
AN for 20 min and dried with a N2 stream. The 
dry residue was dissolved in EtOAc and based on 
100% reaction, various dilutions in the pg range 
were made. The EtOAc solutions were subjected to 
EC/GC analysis. 
An attempt was· made to reduce the DNP 
hydrazone of DHPAcH with sodium cyanoborohydride 
by stirring for 6 hr at room temperature. The pH 
of the reaction mixture was kept constant at 
6 with 1M acetate buffer. The substituted 
hydrazine was extracted with ether. The extract 
was evaporated in vacuum rotary evaporator and 
the dry residue was fluoroacylated according to 
the procedure described before. The dry residue 
was dissolved in EtOAc, and dilutions in the pg range 
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were injected into GC for EC/GC analysis. 
H. REACTION OF PENTAFLUOROPHENYL HYDRAZINE WITH 
DHPAcH & DERIVATIZATION OF THE PRODUCT FOR EC/GC 
ANALYSIS 
Approximately 0.33 mM of DHPAcH(estimation 
based on the starting NE precursor) in 2 ml of 
EtOAc was treated with 0.60 mM of pentafluoro-
phenyl hydrazine dissolved in 2 ml of methanol 
and 1 ml of glacial acetic acid. Total volume of 
reaction solution was 5 ml. The reaction was 
allowed to proceed over a period of 12 hr. 
Samples(0.5 ml) were taken at 3 hr, 8 hr and 12 hr 
reaction time. These samples were immediately 
evaporated to dryness with a N2 stream • The 
residue was treated with 0.5 ml of HFBA and 0.25 
ml of AN for 20 min. The reaction mixture was 
evaporated to dryness with a N2 stream. Dilution 
(1:105) of this residue was made in EtOAc and 
subjected to EC/GC analysis on 5% GEXF 1105 
(GCQ 80-100). The carrier gas flow rate was 
25 ml/min. The detector, column and injector temper-
atures were 240°C, 170°C and 200°C respectively. 
I. REACTION OF NH20H WITH CRUDE DHPAcH & 
DERIVATIZATION OF THE PRODUCTS FOR EC[GC ANALYSIS 
-28-
Approximately 0.2 mM of DHPAcH(estimation 
based on the starting NE precursor) in 1.5 ml of 
EtOAc was treated with 0.90 mM NH20H and 28 
mg sodium acetate in 1 ml H2o. A small amount 
(2 ml of 95%) ethanol was added to effect solution. 
The whole solution was stirred vigorously for 3 
min. Then it was cooled in ice. The sides of 
the test tube were scratched with a glass rod. 
After 5 min the crystals were filtered, washed with 
absolute EtOH and dried. Fluoroacylation was performed 
by treating 1 mg of the crystals with 0.2 ml HFBA 
and 0.1 ml AN. The mixture was allowed to stand for 
20 min at room temperature and evaporated to dryness 
with a N2 stream. Dilutions in pg range in EtOAc 
were injected into GC for EC/GC analysis. 
J. REDUCTIVE TRAPPING METHODS WITH NaBH3CN 
1. Attempt to reduce endogenous DHPAcH in extracts 
of whole rat brain: 
A standard curve was obtained with 
commercially available DHPG. Fluoroacylation was 
done by treating 1 mg DHPG with 0.2 ml HFBA 
and 0.1 ml AN at room temperature for 20 min. 
The solution was evaporated to dryness with N2 
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and the dry residue was dissolved in EtOAc. 
Dilutions of pg range were analysed by EC/GC. 
Whole rat brain tissue (2.253 gm) was 
homogenized for 10 min in 3 ml of 1N HCl04, 
containing 5 ruM Na2s2o3 and 500 rug of NaBH3cN. 
The homogenate was transferred to a conical flask 
and the solution was stirred with a stirring bar for 
2 hr at room temperature. During this period the pH 
was kept at 3-4 by adding 2N HCl dropwise. The 
homogenate was centrifuged at 2000 rpm for 20 min. 
The residue was discarded and the supernatant 
was treated with gm activated alumina. The pH was 
adjusted to 8-8.4 with 0.5 N NaOH. The mixture 
was shaken for 10 min with a mechanical shaker. 
The supernatant was discarded a~d alumina was 
washed twice with distilled H2o. The catechol 
compounds were eluted with 0.1 N HCl and the 
acid eluant was freezedried. The residue was treated 
with 0.5 rul AN and 1 ml HFBA for 20 min. The 
reaction mixture was evaporated to dryness with 
N2. The residue was dissolved in EtOAc and 1: 1 o5 
dilution was injected into the GC for EC/GC 
analysis. 
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A control experiment was done where 2.3 
gm of whole rat brain tissue were homogenized in 
a similar manner, without NaBH3cN. The column used 
for EC/GC analysis was 5% SE-30 on GCQ 80-100 
mesh. The carrier gas flow rate was 30 ml/min. 
The detector, injector and column temperatures 
were 250°C, 230°C, and 170°C respectively. 
2. Reductive amination(52) of DHPAcH with CH3NH2 
and NaBH3 cN(epinine formati.on) and HFB derivative 
formation for EC/GC analysis. 
An estimated amount of 2.07 mM DHPAcH 
in 2 ml of EtOAc was added to a mixture of 
3 ml methylamine(40% solution in H20) and 10 ml 
1 N HC104 containing 
4 mM NaBH3 CN and an 
(35 ml) were added 
5 mM Na2s2o3 • Immediately 
excess of 1 M acetate buffer 
to maintain the pH at 6 
during the reduction process. The total volume of 
the reaction solution was 50 ml. The reaction 
solution was stirred at room temperature through-
out. Samples of 5 ml were taken out at 10 min, 
1 hr and 2 hr intervals. To each sample, 0.5 gm 
activated alumina was added, 
pH adjustment to 8- 8.2 
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followed by a 
with 0.5 N 
.,1 II 
!li.'li 
:1 
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NaOH. The mixture was subjected to 10 min mechani-
cal shaking. The supernatant was discarded and 
alumina was successively suspended in 3-5 ml por-
tions of distilled H2o, and finally was shaken 
10 min at room temperature in 2 ml 0.1 N HCl. 
The HCl supernatant containing eluted epinine 
was decanted, lyophylized and treated with 1 ml 
HFBA and 0.5 ml AN for 20 min at room tempera-
ture. The reaction mixture was evaporated to dryness 
with N2. The residue was dissolved in EtOAc < 1 : i o5 
dilution) and injected into the GC. The column 
used for analysis was 5% GEXF 1105 on GCQ 80-100 
mesh. Carrier gas flow rate was 30ml/min. The 
detector, injector and column temperatures were 280°c, 
240°C and 175°C respectively. 
3. Reductive 
isopropxlamine 
To 
the formation 
amination of 
and NaBH';(CN 
./ 
establish the 
of an amine 
uh~ny]acetaldehyde with 
& GC analysis wj.th FID. 
optimum conditions for 
by reductive amination 
of an aldehyde, phenylacetaldehyde was treated with 
isopropylamine and NaBH3 CN under four different 
sets of conditions and the extent of formation of 
presumed product N-isopropyl phenylethylamine was 
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determined in each case. 
(a) One step procedure(pH 6) at room temperature 
or at 0°C. 
An accurately measured 2 mM of phenyl-
acetaldehyde was suspended in 5 ml of absolute 
EtOH, followed by the addition of 15 ml 1 N 
acetate buffer pH 6 and 9 ml 1 N HClo4 , containing 
5 mM Na2s2o3• The total volume of the mixture 
was 30 ml. The pH of the mixture was 6. Finally 
6 mN of NaBH3cN was added and the :mixture was 
stirred throughout at room temperature. Aliquots(2 ml) 
were removed at 0,5,15,30,45,60 and 120 min of 
reaction time •. The pH of each aliquot was adjusted 
to 10-11 with 4 N NaOH followed by the extraction 
of the product with 2 ml ether twice. The ether 
extracts were evaporated to 0.5 ml, stored in the 
freezer until analysis, and were analysed directly 
w!th FID on 3% OV-17 on GCQ (80-100 mesh).The 
column, detector and injector temperatures were 
110°C, 240°C and 200°C respectively. 
After dissolving 2 mM phenylacetaldehyde 
in absolute alcohol at room temperature, the rest of 
the experiment was carried out at 0°C in a similar 
fashion as before. 
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(b) TVlo step (pH 3-4 & pH 6) procedure at 
room temperature or at o0 c 
Accurately measured 2 mM of phenylacetalde-
hyde was suspended in 5 ml of absolute EtOH, 
followed by the addition of 9 ml 1 N HCl0
4
, 
containing 5 mM Na2s2o3• Finally 20 mM isopropyl-
amine was added. The contents were mixed and 
allowed to stand at pH 3-4 at room temperature 
for 5 min. Then 15 ml 1N acetate buffer, pH 6, 
was added to the reaction solution in order to 
keep the pH constant at 6, followed by the 
addition of 6 mN NaBH3CN. The reaction solution 
was stirred throughout and samples were taken 
out at 0,5,15,30,45,60 and 120 min of reaction time. 
The pH of each sample was adjusted to 10-11 
with 4N NaOH. Accurately measured 0.5 ml 
solution(H2o), containing 4 mg of 1-methylisoquino-
line, was added to each sample as an external 
standard. The reaction product was extracted 
with 2 ml of ether 
to 0.5 ml with a 
by GC with FID 
mesh) column. The 
was 21ml/min. The 
twice. The extract was reduced 
N2 stream and was analysed 
on 3% OV-17 on GCQ(80-100 
carrier gas flow rate 
column, the detector and 
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injector temperatures were 110°C, 240°C. and 200°c 
respectively. 
For the reaction at o0 c, 2 mM phenyl-
acetaldehyde was dissolved in 5 ml absolute EtOH 
at room temperature and rest of the reaction was 
carried out at 0°C (ice bath) in a similar manner 
as above. 
STANDARD CURVE 
The reaction of phenyl acetaldehyde with 
isopropylamine was carried out in one step at pH 
6 and at room temperature for 12 hr. The products 
were extracted with ether and extract was evaporated 
under vacuum. The oily material remaining was vacuum 
distilled. The first fraction came over at 37°C at 
2 mm pressure and second fraction came over at 
56°c. By comparison and elimination process, it 
was determined that 
retention time of 7 
N-isopropylphenylethylamine has a 
0 
min at 110 C, column temperature. 
The carrier gas flow rate was 21ml/min and injector 
and detector temperatures were 200°C and 230°C res-
pectively. The first fraction gave a· similar major 
peak (Fig 5). The fraction was almost pure and this 
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Fig. 5 Chromatogram 
phenylethylamine peak 
showing suspected 
with retention 
N-isopropyl-
time of 7 
min in first fraction. 
GC Conditions: FID, 3% OV-17 on 80-100 GCQ, 
Tc = 110°c, Ti 200°c, Td 0 N2 flow rate = :: 240 c, = 
21ml/min, Att =4 X 10-11. 
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oil was used to make standard curve by injecting 
it directly. 
PRELIMINARY REDUCTIVE At1INATION OF CATECHOLALDEHYDES 
IN WHOLE RAT BRAIN 
Whole rat brain tissue(2.319 gm) was 
homogenized in 2 rnl of 5 rnM Na2s2o3
/1N HClo
4
• 
During homogenization 500 mg pargyline(MAO inhibitor), 
20 mM(1260 mg) NaBH3 CN and 20 mM(620 rng) methylamine 
were added. After homogenization the pH was adjusted 
to 6 with 1M acetate buffer. The mixture was 
stirred for 2 hr at room temperature followed 
by centrifugation(2000 rpm) for 20 min at 4°C. The 
supernatant was treated with 2 mg activated alumina 
and the pH was adjusted to 8-8.2 with 0.2N NaOH, 
followed by mechanical shaking for 10 min. The 
supernatant was discarded. The alumina was successively 
suspended in three 5 ml portions of distilled H2o, 
which were discarded and finally was shaken 10 min 
at room temperature in 4 ml 0.1N HCl. The HCl 
supernatant, containing eluted catechols, was decanted 
and lyophylized. The residue was treated with 
1 ml HFBA and 0.5 ml acetonitrile ·for 20 min at 
room temperature. The reaction mixture was 
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evaporated to dryness with a N2 stream and was 
dissolved in EtOAc and 1:105 dilution was injected 
into GC for EC/GC analysis. 
A similar control experiment was done 
in which 2.411 gm whole rat brain tissue were 
homogenized in 2 ml 5 mM Na2s2o3/1N HCl04, 
containing 500 mg pargyline and 20 mM(1260 mg) 
NaBH3cN. Catechols were extracted with activated 
alumina and prepared for EC/GC analysis as 
above. 
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CHAPTER III 
RESULTS 
A. FLUOROACYLATION OF CATECHOLAHINES AND DERIVED 
CATECHOLALDEHYDES 
Most of the work for making a suitable 
derivative for electron capture detection has been 
done with CAs. Heptafluorobutyrate derivatives 
of CAs were found to be quite stable and 
suitable for electron capture detection (Fig_ 6). 
HFB derivatives of E, NE and DM each 
separate as single peaks on column packed with 
5% GEXF-1105(on Gas Chrom Q, 80-100 mesh). 
E and DH give a single peak on columns packed 
with 3% OV-17 or 5% SE-30. The HFB derivatives 
of all CAs are stable for 2-3 days at -20°C, 
after this time the HFB derivative decomposes 
as judged by the multiple peaks obtained on 
chromatogram. Relative detector responses for E,NE 
and DM are shown in fig 7. The detector response 
for DM is very high. As little as 1-2 pg of 
DH can be detected. The response for J\TE and E 
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Fig. 6 Fluoroacylation of epinephrine with 
HFBA & acetonitrile. 
-40-
,...... 
• (/) 
s 
(.) 
~ 
+l 
fo 
·n (!) 
.c 
~ 
(!) 
Pot 
16 
1 
4 
40 80 120 1 60 200 
Concentration(pg) 
Fig. 7 Comparative detector responses for E, 
NE 1 and DM 
GC conditions: Tc = 175°C, Ti = 210°c, Td = 250oc. 
N2 flow rate= 30 ml/min, Att = 4xlo- 10, 
column 5% GEXF-1105 on GCQ 80-100. 
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is not as high but it is acceptable. 
Similarly the HFB derivative of DHPG 
and epinine each gave a single peak. The HFB 
derivative of the product from the reaction of 
pentafluorophenyl· hydrazine with crude DHPAcH, 
and the HFB drivative of the product from reaction 
of hydroxylamine with crude DHPAcH each gave one 
major peak and one minor peak on. 5% GEXF-1105. 
The two peaks from the reaction product of 
DHPAcH with pentafluorophenyl hydrazine can be 
explained on the basis that the hydrazone of 
DHPAcH has both cis and trans isomers. Similarly 
the reaction product of hydroxylamine and DHPAcH, 
e.g. oxime of DHPAcH, also has cis and trans 
isomers. HFB-DHPG gave a single peak on 5% SE-30. 
HFB-epinine gave a single peak on 3% OV-17 as 
well as on 5% GEXF-1105. 
B. % RECOVERY OF DHP.AcH '!/HEN PREPARED BY FELLHAN' S 
HETHOD (?lt) 
Total activity added in the beginning 
can be calculated as follows: 
Total activity 
= 2.06x106 x 
(dpm/ml) 
present in 24 microliter of 
0.024 x 0.813 = 40195 dpm 
(ml) 
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toluene 
C.E. =(Net count rate of sample + standard)-(Net 
rate of sample) 
Disintegration rate of standard 
= 30 1 0 5 - 96 6 8 = 0 • 1 5 
40195 
dpm sample = 9668 = 18959 
0.51 
Total activity (3H NE) added = 18259 x 3000 
25 
= 2275080 dpm 
Total activity recovered at the end of experi-
ment can be calculated as follows: 
Total activity present in 20 micro litre 
toluene = 2.06 x 106 x 0.02 x 0.813 = 33495 dpm 
(dpm/ml) (ml) (fraction 
dpm 
10118- 300 
33495 
sample = -4Q.Q 
0.29 
= 
of activity) 
0.29 
= 1035 
1 02r:; X 1,3000 Total activity recovered = ~~~~,~--~.~~
20 
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of 
% Recovery 
=672750 dpm 
= 
~72750 X 100 ---....~2~2~7r--;5o=:-r8-r,:;o:---- = 30% 
C. EC/GC A"i'.fALYSIS OF . 2, 4-DINITROPHENYL HYDRAZONE 
OF DHPAcH 
The ·HFB and PFP derivative of 2,4-
dinitrophenyl hydrazone of DHPAcH g~ve no peaks 
at 3% OV-17, 5% GEXF 1105 and 5% SE-30 on 
GC~ 80-100 mesh at any column temperature 
between l30°C and 210°c. 
An attempt was made to reduce the 
hydrazone with TIT RH C''T ~•a"- '3 .,., at pH 6. The HFB derivative 
of reduced hydrazone r:;ave no peak on 5% GEXF-
1105 from 130°C to 0 210 c. The whol& reaction 
can be written as shown in f" .. lg 8. 
D. EC/GC ANI\LYSIS OF THE REACTION OF PENTA;.. 
FLUOROPHENYL HYDRAZINE Vli'.rH D~IPAcH 
A single HFB derivative of the reaction 
product of pentafluorophenyl hydrazine with DHPAcH 
(tentatively assumed to be the HFB-pentafluoro-
phenyl hydrazone of DHPAcH) could be detected 
-41+-· 
HO 
HO 
CHO 
+ 
HO 
HO 
0 M.P.=170 C 
HFBA 
+ 
AN 
bis-heptafluorobutyryl 
derivative 
(no EC response) 
N-NH 
~ N02 
~ 
N02 
NaBH3CN 
pH 6 
Substituted hydrazine 
ll!FBA + AN 
bis-heptafluoro butyryl 
derivativ~no EC response) 
Fig.8 Reaction of 2,4-dinitrophenyl hydrazine with 
DHPAcH reduction &/or HFB derivative formation. 
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L 
by electron capture detector. The standard curve 
for this HFB-pentafluorophenyl hydrazone of DHPAcH, 
is shown in Fig. 9. The l~DQ was 5 pg at the 
conditions shown. The standard curve was drawn 
after running the reaction for 24 hr and 
assuming that 700/J of reaction has been completed. 
The melting point of this hydrazone was not 
in literature and it was not crystallised for 
elemental analysis and melting point determination. 
The reaction progress was determined for 
the formation of pentafluorophenyl hydrazone of 
DHPAcH by following the reaction for 12 hr. 
The reaction progress curve is shown in Fig.10. 
E. EC/GC ANALYSIS OF THE REACTION PRODUCT OF 
HYDROXYLAMINE AND DHPAcH AFTEH HFB-DERIVATIVE 
FORHATION 
The reaction of DHPAcH with NH20H is 
very fast, and crystallization of the reaction 
product(3,4-dihydroxyphenyl acetaldoxime ) seemed 
to be complete in 15-20 min •. HFB derivative ·of 
3,4-dihydroxyphenyl acetaldoxime gave a single peak on 
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F.ig.9 Standard curve for the HFB derivatized 
reaction product of pentafluorophenyl hydrazine 
with DHPAcH. 
GC Conditions: Tc = 170°c, Ti = 200°c, Td = 240°c, 
N2 flow rate = 25ml/min, Att. = 4 x 1o-10 
RT = 6 min 15 sec. 
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Reaction 
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12 15 
Fig.10 Reaction progress 
of reaction product of 
and DHPAcH. 
curve for the formation 
pentafluorophenyl hydrazine 
GC Conditions: Tc =170°C, Ti = 200°C, Td = 240°C, 
-10 Att = 4 x 10 , N2 flow rate = 25ml/min, 
RT = 6 min 15 sec, Column 5% GEXF-1105. 
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1: 
I 
5% GEXF-1105 on GCQ 80-100 mesh. The retention 
time was 5 min 30 sec at a N2 flow rate of 
23ml/min and injector, detector and column tempera-
tures of 200°C, 240°C and 180°C respectively. The 
MDQ was 500 pg. The standard curve for HFB-3,4-
dihydroxyphenyl acetaldoxime is shown in fig. 11. 
The probable reaction of NH20H with DHPAcH is 
shown in fig. 12. 
F. l$EDUCTION QF DHPAcH WITH SODIUM CYANOBORO-, 
HYDRIDE & EC/GC ANALYSIS OF HFB-DHPG. 
Commercial DHPG was used to obtain the 
standard curve. The HFB-DHPG standard curve is as 
shown in fig.13. The HDQ was 40 pg at 170°C on 
a 5% SE-30 column. The injector a.'1.d detector tem-
peratures were 230°C and 250°C respectively. Higher 
temperatures were tried and up to 200°C the sensiti-
vity was about the same; but at 210°C up to 1-2 
pg of DHPG can be detected. The only drawback at 
210°C is that, there is no resolution between CAs 
and DHPG. The reduction of DHPAcH can be written 
as in fig. 14. 
G. MEASUREMENT OF IN VIVO CATECHOLALDEHYDE LEVELS 
AS DHPG 
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s 
32 
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Concentration (ng) 
Fig. 11. Standard curve for the reaction product 
of DHPAcH with NH20H (probable reaction product; 
3,4- dihydroxyphenyl acetaldoxime). 
GC Conditions: Tc = 180°C, Ti = 200°C, 0 Td = 240 C, 
N2 flow rate= 23ml/min, Column 5% GEXF-1105 on 
GCQ 80-100 mesh. 
RT = 5 min 30 sec, MDQ = 500 pg. 
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DHPAcH 
H=NOH 
3,4-Dihydroxyphenyl-
acetaldoxime 
HFBA + AN 
bis-HFB-derivative 
(volatile) 
Fig. 12. Probable reaction of NH20H with DHPAcH, 
and fluoroacylation of expected 3,4-dihydroxy-
phenylacetaldoxime(product of reaction ). 
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r 
16 
Concentration 
Fig. 13. Standard 
GC Conditions: Tc 
RT = 6 min, Att. = 
min. 
DHPG(pg) 
curve for 
= 170°c, Td 
4 X 10-10 , 
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400 500 
DHPG. 
= 250°C, 
N2 flow 
Ti = 230°C, 
rate = 30ml/ 
HO 
HO 
DHPAcH 
HO HO 
N~BH3~ 
H' HO 
DHPG 
HFBA + AN 
bis-HFB derivative 
(volatile) 
Fig. 14. Reduction of DHPAcH with NaBH3CN at 
pH 3-4. 
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In whole rat brain(control without any 
addition of NaBH3CN), a peak for DHPG was observed 
by EC/GC analysis. In experimental whole brain 
the DHPG peak was obtained but it was some what 
smaller than control. 
The DHPAcH level = DHPG level after reduction 
\rlth NaBH3CN -(DHPG level in 
control) 
By this calculation the DHPAcH level in brain 
comes out to be negative which is impossible 
as there is enough indirect evidence for the 
positive catecholaldehyde levels in brain. 
H. TRAPPING SYNTHETIC DIHYDROXYPHENYL ACETALDEHYDE 
OR PHENYLACETALDEHYDE VIA REDUCTIVE AMINATION 
The reaction conditions for the forma-
tion of an amine by reductive amination of alde-
hyde, were established by treating isopropylamine 
with phenyl acetaldehyde under four different 
sets of conditions, as discussed in materials and 
methods. The standard curve for the product, 
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tentatively called N-isopropylphenyl ethylamine, 
was drawn as shown in fig. 15 (obtained on the 
flame ionization detector). The % yield of N-iso-
propylphenyl ethylamine in one step preparation 
and two step preparation at room temperature and 
0°C were plotted in each case as shown in fig. 
16 .· and fig. 17 respectively. The most probable 
reaction for one step and two step processes are 
as shown in fig. 18. 
Epinine was prepared by treating DHPAcH 
with methylamine at pH 6 and reducing with 
NaBH3CN at pH 6. The reaction yield was followed 
by taking out 5 ml samples at different time 
intervals. Yield of epinine was calculated by com-
paring peak heights to the HFB-epinine standard 
curve as shown in fig.19~ The retention time for 
epinine was 3 min at conditions mentioned in ex-
perimental and HDQ was 25-30 pg. The yield of 
epinine was calculated as follows: 
The 10 min sample(5 ml) diluted to 1:105 times 
has epinine as read from standard curve = 30 pg 
Epinine concentration in 5 ml sample = 30 x 105 
Total epinine in 50 ml = 30 x 105 x 10 
= 30 mg 
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Fig. 15 Standard curve for the product obtained by 
reductive amination of phenyl acetaldehyde with iso-
propyl amine and reaction product tentati-
vely called N-isopropylphenyl ethylamine) 
GC Conditions: On GCQ 80-100 mesh, 
0 Tc = 110 c, 
3% OV-17 
Td = 230°C, flow rate= 
2lml/min, Flame ionization detector. 
RT = 7 min. 
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30 
10 
temperature 
0 0 
X 
. 
20 40 60 80 100 120 
Reaction time (min) 
Fig. 16 The % yield of the product (obtained by 
reductive amination of phenyl acetaldehyde with 
isopropyl~mine and NaBH3CN) in one step preparation 
at pH 6 at different reaction times. 
GC Conditions: 3% OV-17 on GCQ 80-100 mesh, 
Tc = 110°c, Ti = 200°c, Td = 230°c, N2 flow rate= 
21ml/min, Flame ionization detector. 
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40 
30 
temperature 
I 
20 
, 
40 
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Reaction time (min) 
Fig.17 The %yield of the product( obtained 
by reductive amination of phenyl acetaldehyde 
with isopropylamine and NaBH3 CN) in two step 
preparation ( pH 3-4 and pH 6) at different 
reaction times. 
GC Conditions: 3% OV-17> on GCQ 80-100 mesh, 
Tc = 110°C, Ti = 200°C, Td = 230°C, N2 flow rate= 
21ml/min, Flame ionization detector. 
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CHO 
pH 6 
+ 
(a) One step preparation. 
CHO 
+ 
(b) Two step 
preparation 
pH 3-4 
Fig. 18 The most probable reaction for reductive 
amination of phenyl acetaldehyde with isopropylamine 
and NaBH3CN in one step and two step preparation. 
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Fig. 19 Standard curve for epinine,HFB derivative). 
GC Conditions: 5% GEXF-1105 on GCQ 80-100 mesh, 
N2 flow rate = 30ml/min, Att.= 4 X 10-10, Tc = 175° c, 
Ti = 240°c, Td ::: 280°c. 
RT = 3 min, MDQ = 25-30 pg. 
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Similarly total epinine at hr = 133 mg 
and at 2 hr = 144 mg 
The % recoveries of epinine at various reaction 
times are shown in table 1 • The whole reaction 
for the formation of epinine is shown in 
Fig. 20. 
I. TESTING THE REDUCTIVE .4MINATION HETHOD WITH 
BRAIN TISSUE 
This method was tested by measuring 
epinine formation in whole rat brain. There 
is no epinine present in the rat brain; 
but there was a small peak for epinine in 
the experimental sample, which contained methyl-
amine and NaBH3cN. However, a control with 
methylamine only should be included in future 
studies. With this method it is possible that 
dopaldehyde levels can be read directly as 
epinine. The chromatogram of the HFB-catechol 
compounds from whole rat brain after reaction 
with methylamine and reduction with NaBH3CN at 
pH 6 for 2 hr is shown in Fig.21. 
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Total 
sampl Total Initial Rx SamplE SamplE Epi- opi- Epi- % 
amt. time ivolume volumE dil nine nine nine Yield 
m't-1 min ml ml pg pg mM 
2.07 10 50 5 1:1 o5 30 30 0.19 o/lo 
2.07 60 50 5 1: 1 o5 133 133 o.8o 39% 
2.07 120 50 5 1: 1 o5 144 144 0.84 41% 
Table 1. %Recoveries of epinine at various 
reaction times. 
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r 
I . 
HO 
HO 
DHPAcH 
Epinine 
HFBA & AN 
bis-HFB derivative 
Fig. 20 Formation of epinine by reductive 
amination with NaBH_3CN & CH_3NH2 at pH 6. 
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Fig. 21. EC/GC chromatogram of the HFB-catechol 
compounds from whole rat brain after reduction 
with NaBH3cN at pH 6 for 2 hr,cH3NH2 present). 
GC Conditions: 3% OV-17 on GCQ 80-100; Tc~160°C; 
o o I 8 -1o Td=250 C; ~~i==200 C; N2 flow rate=30ml min, Att.~ xlO • 
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CHAPTER FOUR 
DISCUSSION & CONCLUSIONS 
Four different approaches were tried to 
establish a reliable and sensitive method for the 
mc;_-,_surement of catecholaldehyde levels in brain 
tissue. The first e.pproach was to measure catechol-
aldehyde levels as the 2,4-dinitrophenyl hydrazone 
derivative. There was no electron capture 
response for HFB or PFP derivative on 3% OV-17, 
5% GEXF -1105, or 5% SE-30. On the other hand 
HFB-pentafluorophenyl hydrazone derivative gave 
a very good electron capture response. The 
minimum detectable quantity was 5 pg on 5% GEXF 
1105 (on GCQ 80-100 mesh) at 170°C and carrier 
gas flow rate of 25 ml/min. The only drawback 
with this method was that it takes 12 hr to 
get a fairly good yield (65%) of pentafluorophenyl 
hydrazone of DHPAcH. The 2,4-dinitrophenyl hydrazone 
preparation takes only 1/2 hr but it does not 
show any electron capture response. It was 
apparent that the HFB- or PFP- 2,4-dinitrophenyl 
hydrazone of DHPAcH was not volatile. 
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r 
The second approach was to trap 
aldehydes as oxime derivative. The reaction 
time was only 15 min, but the electron 
capture response for this derivative was not 
very great. The minimum detectable quantity was 
500 pg. 
The third approach was to reduce 
DHPAcH with NaBH3CN and measure as DHPG. The 
minimum detectable quantity for HFB-DHPG was 
40 pg. The method seemed quite sensitive. But 
when this method was applied to tissue there 
was no difference between DHPG level of control 
and reduced tissue (experimental tissue which 
has been reduced with NaBH3CN at pH 3-4) DHPG. 
In contrast by calculation one comes up with 
a negative number. Possible explanations for 
this observation are; (a) that may be the NaBH
3
cN 
is not reducing the catecholaldehydes as they 
are bound to tissue; (b) that catecholaldehydes 
might have been metabolised by aldehyde dehydro-
genase or by aldehyde reductase in vitro during 
decapitation and homogenization. 
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The fourth approach was to trap 
catecholaldehydes as imines and reduce to an 
ruaine. It is very clear from the one step 
( Fig. 16 ) and two step ( Fig. 17 ) preparations 
of N-isopropylphenyl ethylamine that the optimum 
condition for reductive amination of aldehydes 
is to carry on reductive amination in one 
step at pH 6 at room temperature. 
The reductive amination method was 
established by preparing epinine from DHPAcH 
by treating with methylamine and NaBH CN at pH 
3 
6 for 2 hr. The reaction mixture was stirred 
throughout at room temperature. The epinine 
formed was extracted by binding to activated 
alumina at pH 8-8.2 and then eluting the 
bound epinine wj~h 0.2N HCl. The acid eluate 
was lyophilysed and treated with HFBA and AN 
for 20 min. The fluoroacylated epinine was 
dried under a N2 stream. The HFB-epinine 
gives a single peak on 5% GEXF-1105. The 
minimum detectable quantity was 30 pg. There 
is no apparent epinine present in whole rat 
brain tissue under our conditions. Hence this 
-67-
r 
method has advantage that dopaldehyde levels 
can be read directly as epinine. The E and 
NE derived catecholaldehydes can be measured 
with some modifications of the basic method. 
The HFB-epinine derivative is stable for at 
least 2-3 days. at 0 -20 c. Under the same 
conditions epinine is stable for weeks. The 
catecholaldehydes are very important metabolites 
and this method will help study the catechol-
aldehyde levels in normal, disease or drug 
state. 
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